These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 42418)

  • 1. Antihypertensive effect of intravenously and orally administered bunitrolol (Kö 1366).
    Okabayashi T; Naito S; Arakawa K
    Arzneimittelforschung; 1979; 29(9):1417-21. PubMed ID: 42418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparable ergometric examinations before and after administration of practolol and bunitrolol (author's transl)].
    Pozenel H
    Wien Klin Wochenschr; 1975 Jan; 87(1):19-25. PubMed ID: 236621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
    Jonker JJ; de Klerk J; den Ottolander GJ
    Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of bunitrolol on heart rate, metabolic parameters during physical exercise, and performance].
    Keul J; Lehmann M; Wybitul K
    Arzneimittelforschung; 1981; 31(11):1948-53. PubMed ID: 6119096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
    Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M; Burkart F; Bühler FR; Schweizer W
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of bunitrolol in essential hypertension.
    Yoshimura M; Shikuma R; Takashina R; Takeda K; Takahashi H; Ijichi H; Kajita Y; Yamazaki H
    Arzneimittelforschung; 1983; 33(8):1181-4. PubMed ID: 6139114
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
    Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A
    Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P
    Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypotensive effects of timolol in 86 patients (author's transl)].
    Lagrue G; Gumpelson A; Kazandjan M; Grillot A
    Sem Hop; 1978 Oct 8-15; 54(29-32):929-32. PubMed ID: 216083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute hemodynamic effects of betaxolol in uncomplicated arterial hypertension in young persons].
    Carré AG; Bertrand ME; Libersa CC; Demerville JC; Lekieffre JP
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():171-5. PubMed ID: 6810822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
    Gloger K
    Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bucindolol in essential hypertension.
    Reid JL; Curzio J; Vincent J
    Int J Clin Pharmacol Res; 1985; 5(5):293-301. PubMed ID: 2866166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.